MedTrace Logo

Effects of Kinesio Taping on Thoracolumbar Fascia Flexibility in Patients With Shoulder Injury

NCT07624136 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2026-06-03

No results posted yet for this study

Summary

The aim of this randomized controlled trial is to investigate the acute effects of fascia correction Kinesio Taping applied to the thoracolumbar fascia (TLF) in individuals with Subacromial Impingement Syndrome (SIS). Participants will be randomly allocated into an intervention group and a sham taping control group. The intervention group will receive fascia correction Kinesio Taping applied to the thoracolumbar region, while the control group will receive sham taping without therapeutic effect. Clinical parameters including pain intensity, trunk range of motion, thoracolumbar fascia flexibility, lumbar mobility, and posterior shoulder capsule tightness will be assessed before the intervention and 45 minutes after the application. This study aims to provide evidence regarding the acute clinical effects of thoracolumbar fascia modulation in individuals with Subacromial Impingement Syndrome.

Conditions

  • Subacromial Impingement Syndrome
  • Shoulder Pain

Interventions

OTHER

kinesio taping

Assessments will be performed immediately before the intervention and 45 minutes after tape application in both groups. Outcome measures will include pain intensity during rest and activity assessed using the Visual Analog Scale (VAS), trunk range of motion measured by goniometry, trunk flexibility assessed by tape measurements, thoracolumbar fascia flexibility evaluated using a goniometric platform, lumbar mobility assessed by the Modified Schober Test, and posterior shoulder capsule tightness. Participants in the intervention group will receive corrective kinesio taping applied in a horn-shaped configuration, whereas the sham group will receive a tension-free tape application from the lateral trunk/axillary region toward the hip without therapeutic fascial correction.

Sponsors & Collaborators

  • Kübra Sarıoğlu

    lead OTHER

Principal Investigators

  • KÜBRA SARIOĞLU, PhD · HACETTEPE ÜNİVERSİTESİ ,Anafartalar, Talatpaşa Blv No:47, 06100 Altındağ/Ankara

  • Gül Baltacı, Prof.Dr. · Atlas University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-05-20
Primary Completion
2026-09-20
Completion
2026-09-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07624136 on ClinicalTrials.gov